Director/PDMR Shareholding

Smith & Nephew Plc

03 May 2023

 

SMITH & NEPHEW PLC

3 May 2023

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMR") AND PERSONS CLOSELY ASSOCIATED WITH THEM.

Reason for the notification
Initial notification /Amendment	Initial notification
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
Name	Smith & Nephew plc
LEI	213800ZTMDN8S67S1H61
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
Description of the financial instrument, type of instrument	Smith & Nephew plc ordinary shares of USD 0.20 each
Identification code	ISIN: GB0009223206
Nature of the transaction	Sale of ordinary shares. Following the sale, each individual continues to maintain a shareholding in accordance with the shareholding guidelines.
Date of Transaction	Phil Cowdy: 2023 - 04 - 27 & Bradley Cannon: 2023 - 05 - 02
Place of Transaction	London Stock Exchange (XLON)

Name (Position)	Director / PDMR	Price (£)	Volume	Aggregated information	Total Ordinary Share Holding following the transaction *	Total Ordinary Share Holding as a % of the Company's ISC following the transaction *
Phil Cowdy (Chief Corporate Development and Corporate Affairs Officer)	PDMR	12.83280	12,083	N/A Single Transaction	49,000.99309 ordinary shares	0.00558%
Bradley Cannon (President, Global Orthopaedics)	PDMR	12.926813	9,500	N/A Single Transaction	117,819.37494 ordinary shares (including 3,599.09977 in ADS')	0.01342%

* including those held by Persons Closely Associated with the Director/PDMR. All figures in these columns are stated to 5 decimal places where applicable.

Helen Barraclough

Company Secretary

Smith & Nephew plc

Tel:  [phone]

 

END